An international, peer reviewed, open access journal that focuses on dissemination of novel genetic, epigenetic and molecular pathway information related to clinical cancer. Of particular interest is the exploration of translational connections to human cancer from basic science to ethical considerations related to the application of oncogenomic discoveries for diagnostic and prognostic purposes in clinical trials and for anti-cancer drug development.
Editor in Chief: Dr. Todd W. Miller
Processing Speed: High quality, constructive peer review and rapid editorial decision within an average of four weeks.
Sign up for email alerts to receive notifications of new articles published in Translational Oncogenomics
Translational Oncogenomics 2008:3 45-52
As an author of a review published in Translational Oncogenomics, I was impressed by the prompt processing and speed of publication. The entire submission, review and publication process was easy, quick and pleasant. The comments from reviewers and associate editor were high quality, scientifically deep and objective. It was a great pleasure to cooperate with such qualified and friendly team.